Maturation of dendritic cells determines whether an antigenwill elicit a tolerogenic or immunogenicresponse. Endogenous pathways are required to maintain peripheral tolerance to self-antigens by deleting,anergizing or expanding T regulatory cells. Work during the past funding period of this program projectrevealed that IgG immune complexes can promotestrongly immunogenic responses if the normalinhibitoryconstraint is overcome. We will test the hypothesisthat IgG immune complexes, in the steadystate,maintain tolerance through distinct DC subsets by preferentially eliciting inhibitory receptor signaling. Thisendogenous pathwayhas been shown to be perturbed in autoimmune susceptible mouse strains and humanpopulation. This hypothesiswill be tested by 1) Determining the contribution of the inhibitory FcRexpressed on DCsubsets to the autoimmune phenotype; 2) Blocking activation or inhibitory FcRsignaling on DCs in novel FcR humanized mouse models to determine their contribution to developor maintenance of autoimmunity and 3) Dissecting the FcR signaling pathway on DCs that eitherpromotes immunity or tolerance and its potential synergy with TLR signaling pathways. Thesestudies will depend on the reagents and observations developed in the two other projects in this programproject. The results of the studies in this projectwill, in turn, impact on the experimental approachesof theother projects. This synergy will allow us to developapproachesto restore tolerance in autoimmunitythrough the targeting and manipulationof maturationpathways in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI051573-06
Application #
7293737
Study Section
Special Emphasis Panel (ZAI1-MP-I (J1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-15
Budget End
2008-06-30
Support Year
6
Fiscal Year
2007
Total Cost
$341,497
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Sela, Uri; Park, Chae Gyu; Park, Andrew et al. (2016) Dendritic Cells Induce a Subpopulation of IL-12R?2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses. PLoS One 11:e0146412
Guermonprez, Pierre; Helft, Julie; Claser, Carla et al. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 19:730-8
Schreiber, Heidi A; Loschko, Jakob; Karssemeijer, Roos A et al. (2013) Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium. J Exp Med 210:2025-39
Bozzacco, Leonia; Yu, Haiqiang (2013) Identification and quantitation of MHC class II-bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis. Methods Mol Biol 1061:231-43
Bozzacco, Leonia; Yu, Haiqiang; Dengjel, Jorn et al. (2012) Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. PLoS One 7:e41897
Meredith, Matthew M; Liu, Kang; Kamphorst, Alice O et al. (2012) Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 209:1583-93
Meredith, Matthew M; Liu, Kang; Darrasse-Jeze, Guillaume et al. (2012) Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209:1153-65
Wang, Bei; Zaidi, Neeha; He, Li-Zhen et al. (2012) Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Res 14:R39
Bozzacco, Leonia; Yu, Haiqiang; Zebroski, Henry A et al. (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 10:5016-30
Li, Fubin; Ravetch, Jeffrey V (2011) Inhibitory Fc? receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 333:1030-4

Showing the most recent 10 out of 40 publications